{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:46:20Z","timestamp":1762782380998,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jvir.2019.08.033","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T18:18:01Z","timestamp":1579803481000},"page":"401-408.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study"],"prefix":"10.1016","volume":"31","author":[{"given":"Ruoqi","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samdeep","family":"Mouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsun","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2019.08.033_bib1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","volume":"27","author":"Altekruse","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2019.08.033_bib2","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jvir.2019.08.033_bib3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2019.08.033_bib4","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A\u00a0comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jvir.2019.08.033_bib5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2019.08.033_bib6","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: selective internal radiation therapy versus sorafenib in asia-pacific patients with hepatocellular carcinoma","volume":"36","author":"Chow","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2019.08.033_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/liv.12622","article-title":"Safety and toxicity of radioembolization plus sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC","volume":"35","author":"Ricke","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jvir.2019.08.033_bib8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2019.08.033_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2019.08.033_bib10","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2019.08.033_bib11","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jvir.2019.08.033_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12072-014-9533-9","article-title":"Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma","volume":"8","author":"Khor","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jvir.2019.08.033_bib13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.21037\/jgo.2018.03.04","article-title":"Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization","volume":"9","author":"Frakes","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2019.08.033_bib14","first-page":"185","article-title":"Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection","volume":"3","author":"She","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jvir.2019.08.033_bib15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.jvir.2015.07.019","article-title":"Yttrium-90 glass-based microsphere radioembolization in the treatment of hepatocellular carcinoma secondary to the hepatitis b virus: safety, efficacy, and survival","volume":"26","author":"Biederman","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2019.08.033_bib16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2019.08.033_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","article-title":"Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium","volume":"68","author":"Kennedy","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2019.08.033_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fonc.2014.00198","article-title":"Side effects of yttrium-90 radioembolization","volume":"4","author":"Riaz","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.jvir.2019.08.033_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.27057","article-title":"Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy","volume":"60","author":"Vouche","year":"2014","journal-title":"Hepatology"},{"issue":"5 Suppl 1","key":"10.1016\/j.jvir.2019.08.033_bib20","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1053\/j.gastro.2004.09.016","article-title":"Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms","volume":"127","author":"Brechot","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2019.08.033_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1572-0241.2006.00364.x","article-title":"Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma","volume":"101","author":"Cantarini","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2019.08.033_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2019.08.033_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2019.08.033_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejca.2011.12.021","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"48","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2019.08.033_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2019.08.033_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jvir.2019.08.033_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02007-17","article-title":"Hepatitis B virus DNA integration occurs early in the viral life cycle in an in\u00a0vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles","volume":"92","author":"Tu","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jvir.2019.08.033_bib28","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1096\/fj.06-7345com","article-title":"Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity","volume":"21","author":"Li","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.jvir.2019.08.033_bib29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.21037\/jgo.2017.08.03","article-title":"Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study","volume":"8","author":"Mantry","year":"2017","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2019.08.033_bib30","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00270-013-0547-9","article-title":"Safety of repeated yttrium-90 radioembolization","volume":"36","author":"Lam","year":"2013","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044319308085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044319308085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:03:57Z","timestamp":1760940237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044319308085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1051044319308085"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2019.08.033","relation":{},"ISSN":["1051-0443"],"issn-type":[{"type":"print","value":"1051-0443"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2019.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2019","name":"copyright","label":"Copyright"}]}}